Log in to your Inderes Free account to see all free content on this page.
Scandinavian Real Heart
17.60 SEK
-1.40 %
Less than 1K followers
HEART
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-1.40 %
+14.66 %
+25.71 %
+27.07 %
+19.34 %
+16.59 %
-69.63 %
-93.97 %
-88.60 %
Scandinavian Real Heart operates in the medical technology sector. The company conducts research and development in observations of the physiology of the heart. The development of the company's product, a complete artificial heart, is taking place in collaboration with cardiac surgeons, researchers and engineers. The focus is on developing patented solutions that can imitate the blood circulation of the natural human heart, with the goal of being used by patients diagnosed with heart failure. The company was founded in 2007.
Read moreMarket cap
149.56M SEK
Turnover
84.6K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue K
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
28.5.
2026
General meeting '26
28.8.
2026
Interim report Q2'26
All
Press releases
3rd party
ShowingAll content types
Peer-Reviewed Article Shows Superior Hemolysis Profile in Realheart® TAH Compared to Market-Leading Device
Realheart® TAH and Key Collaborators Featured in New SVT Documentary Series
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio